A tube of blood leaves a patient’s arm at 8:14 AM. By the time a physician reads the results, that single specimen has passed through collection, labeling, transport, accessioning, preparation, testing, reporting, and eventually storage or disposal. Every one of those handoffs is a place where a lab either builds trust or loses it. Lab sample lifecycle management is the discipline of controlling that entire journey so nothing gets lost, delayed, or misidentified along the way.
Most labs know their own corner of this process well. Fewer labs have mapped the full sequence end-to-end, stage by stage, in a way that connects accessioning practices to archiving policy and everything in between. This guide does that. It walks through all seven stages of the modern lab sample lifecycle, the failure points at each stage, and what separates labs with strong sample lifecycle management from those still firefighting mislabeled tubes and missing results.
What Is the Sample Lifecycle in a Modern Lab?
The sample lifecycle is the sequence of stages a specimen moves through from collection to its final disposition or long-term archiving.
Industry conversations use “sample lifecycle” and “sample journey” interchangeably, describing the same thing: the path a specimen travels after it is collected from a patient and enters a laboratory’s custody. In a modern lab running on LIMS sample lifecycle management principles, that path breaks down into seven distinct stages.
- Collection & Accessioning
- Tracking & Chain of Custody
- Specimen Preparation & Segregation
- LIS Integration
- Specimen Processing & Testing
- Home & Decentralized Collection
- Archiving & Retention
Sample lifecycle visibility across these seven stages matters for three concrete reasons:
- It gives the lab traceability when something goes wrong and a patient’s results need to be reconstructed.
- It protects turnaround time (TAT) because delays compound at every handoff a sample makes.
- It determines whether a lab passes or fails a CLIA or CAP inspection, since accreditation bodies audit exactly this kind of chain of custody.
Pre-analytical errors account for almost 60% of the total lab errors reported in the clinical literature. This means that anything that happens to a specimen before it reaches the analyzer contributes majorly to the total error. Nearly all of those errors trace back to a gap somewhere in the sample lifecycle: a missing label, a broken scanner, a specimen sitting too long before centrifugation.
What Are the Stages of the Lab Sample Lifecycle?
A specimen moves through seven sample life cycle stages between collection and final disposition. Understanding what happens to each one and who owns it is the foundation of effective sample lifecycle management.
- Collection & Accessioning: A phlebotomist or collection point draws the sample, labels it, and the lab logs it into the LIMS with a unique accession number.
CoC: Owned by front-desk and collection staff. - Tracking & Chain of Custody: Barcode scans record every handoff from collection through result release.
CoC: Owned jointly by lab operations and quality assurance. - Specimen Preparation & Segregation: The sample is centrifuged, aliquoted, and routed to the correct department based on the tests ordered.
CoC: Owned by processing technicians. - LIS Integration: Orders, statuses, and results sync automatically between the LIMS and hospital or physician-facing systems.
CoC: Owned by IT and integration teams. - Specimen Processing & Testing: The prepared sample runs on an analyzer or bench method and produces a reportable result.
CoC: Owned by bench technologists and the pathologist or signing doctor. - Home & Decentralized Collection: A variant entry path where samples are collected outside the lab and transported in before rejoining the standard flow.
CoC: Owned by phlebotomy dispatch and logistics. - Archiving & Retention: After the results are obtained, the sample is either disposed of or stored for a regulation-defined period.
CoC: Owned by lab management and compliance.
Note: The Home & Decentralized Collection is not a separate track running parallel to the other six stages. It is an alternate front door into the same lifecycle. A home-collected specimen still has to clear accessioning, tracking, preparation, and every other stage, exactly like a sample drawn on-site.
Stage 1: Collection & Accessioning
Accessioning is the process of logging a sample into the lab’s system and assigning it a unique accession number. This number acts as an identifier that carries the sample data. It ties every subsequent action on that specimen back to a single patient and order.
What Happens During the Sample Accessioning Procedure
The sequence at this stage follows a consistent pattern in most labs:
- A phlebotomist or collection technician draws the specimen and applies a label at the bedside or collection point.
- Front-desk or receiving staff log the sample into the LIMS on arrival.
- The system assigns an accession number, typically a combination of a date code, a sequence number, and sometimes a department prefix.
- That number is printed on the sample label, the requisition, and every report generated from it.
Why the Accession Number Is the Backbone of Traceability
An accession number of 24-08-0417H might tell a technologist that the sample arrived in 2024, was the 417th specimen logged that day, and belongs to the hematology department. That single string is what lets a lab pull the chain of custody, results, and billing for that specimen months later without ambiguity. No other identifier in the sample lifecycle carries that much weight on its own.
Common Accessioning Errors and How Labs Can Prevent Them
Two failure points cause most of the trouble at this stage: mislabeling at the point of collection and incomplete requisitions that arrive without a matching order. CAP Q-Probes studies have repeatedly identified specimen labeling errors as one of the most common preventable events in clinical laboratories, occurring often enough that most accredited labs track labeling error rates as a standing quality metric.
Standardized collection containers, such as color-coded tube systems, reduce one layer of that risk by making the correct tube for a given test visually obvious before the sample ever reaches accessioning. Labs looking for a deeper breakdown of the sample accessioning process, including how to reduce mislabeling at the point of collection, can find that in CrelioHealth’s dedicated guide on sample accessioning.
Stage 2: Tracking & Chain of Custody
Chain of custody is the documented, unbroken record of who handled a sample, when, and what happened to it at each step between collection and final disposition.
How Barcode-Based Tracking Makes Chain of Custody Auditable
Barcode-based tracking is what makes the chain of custody auditable in a modern lab. Every time a specimen changes hands, a scan timestamps that event and attaches it to the accession number. Without that scan trail, a lab has no defensible answer when an auditor or a physician asks where a sample was at 11:40 a.m. on a given day.
What Breaks the Chain of Custody?
The chain of custody breaks down in a few predictable ways:
- A handoff happens without a corresponding barcode scan.
- A sample is transported manually between departments with no log of transfer.
- A timestamp is missing or clearly inaccurate, breaking the sequence.
- A specimen is relabeled or split without updating the tracking record to reflect it.
Chain of Custody and CLIA/CAP Audit Readiness
Any one of these gaps becomes a citation risk during a CLIA or CAP inspection, since both frameworks specifically require labs to demonstrate specimen identification and chain of custody as part of their audit trail. Pre-analytical errors, the category that chain-of-custody failures fall into, are consistently identified in the clinical literature as the largest single source of laboratory error, ahead of both analytical and post-analytical errors combined.
Labs preparing for an inspection should treat chain of custody as a standing readiness item, not a pre-audit scramble. CrelioHealth’s guide on specimen chain of custody for regulated labs covers what inspectors check for in more detail.
Stage 3: Specimen Preparation & Segregation
Specimen preparation and segregation indicates splitting, centrifuging, and routing a sample into the correct container and department based on the tests a physician has ordered.
What Happens Physically During the Preparation Stage
This stage covers three main actions:
- Centrifugation is used to separate serum or plasma from whole blood.
- Aliquotting a single draw into multiple containers when a patient’s order spans several departments.
- Route each aliquot to the correct bench based on the test menu ordered.
Color-Coded Container Standardization in Practice
This is also where color-coded container logic, introduced at collection, actually gets applied operationally. A lavender-top tube destined for a CBC gets segregated toward hematology. A gold-top tube for a chemistry panel goes toward the chemistry line. Getting that segregation wrong at this stage, not just at collection, is what forces a recollection.
The Cost of Preparation and Tube-Selection Errors
The most common preparation error is a test routed to the wrong tube or additive type after the fact, often because a late add-on order wasn’t matched correctly against the original draw. When that happens, the specimen typically cannot be used for the newly requested test, and the patient has to be redrawn, adding hours to that patient’s TAT and creating an avoidable second collection event.
Clean segregation at this stage has a direct downstream effect. This is what allows Stage 5, specimen processing and testing, to run without instrument-side delays caused by a technologist stopping to manually sort or re-route a mislabeled aliquot.
Stage 4: LIS Integration
LIS integration means connecting the lab’s LIMS to hospital and physician-facing information systems so that orders, statuses, and results flow automatically in both directions.
What Breaks Without LIS Integration
When a LIMS and LIS aren’t integrated, the consequences show up quickly:
- Staff manually re-key orders that already exist in the hospital’s EHR.
- Physicians wait longer for result delivery because someone has to push data across systems by hand.
- Order context, meaning the clinical reason a test was requested, gets lost somewhere in that manual transfer.
What Bidirectional Interfacing Enables
Bidirectional interfacing solves this by allowing electronic order intake directly into the LIMS and automatic result push-back to the ordering system the moment a report is finalized. That two-way sync is what separates a lab running on LIMS sample lifecycle management principles from one still bridging systems manually.
What to Evaluate in the Best LIMS for Sample Lifecycle Management
For labs evaluating what counts as the best LIMS for sample lifecycle management, this stage is where the evaluation should focus most closely. The right questions to ask a vendor include:
- Does the system support standard interface protocols like HL7 and FHIR?
- Does synchronization happen in real time rather than in scheduled batches?
- Does the audit trail stay continuous across the interface rather than resetting at the integration boundary?
Take a deeper look at how specimen status flows through LIS integration in CrelioHealth’s dedicated LIMS integration guide.
Stage 5: Specimen Processing & Testing
This is the analytical stage, where the prepared specimen is run on an instrument or bench method to produce a reportable result.
How Instrument Worklists Get Built from Clean Upstream Data
Instrument worklists are generated automatically from samples that were properly accessioned and segregated in the earlier stages. A worklist built from clean upstream data lets a technologist run a full batch without manually reconciling missing or duplicate entries.
QC and Validation Checkpoints Before Result Release
Every result passes through a set of gates before it reaches a report:
- Control values must fall within the expected range for that instrument run.
- Delta checks compare a new result against a patient’s prior values to flag unexpected shifts.
- Any flagged result routes to a technologist or pathologist for manual review before release.
How Upstream Data Quality Drives Turnaround Time
TAT performance at this stage is a direct function of how cleanly the sample moved through Stages 1 through 4. A specimen that arrives correctly labeled is segregated without error and synced instantly through LIS integration. This way, data reaches the analyzer with no manual intervention required. A specimen carrying an unresolved issue from any earlier stage almost always adds delay here, since testing is where upstream problems finally surface and have to be corrected before a result can be released. Once a result clears QC, it feeds back into the LIS integration covered in Stage 4, completing the loop between order and report.
Stage 6: Home & Decentralized Collection
Home and decentralized collection is a variant entry point into the same lifecycle, adding logistics and cold-chain steps before the sample reaches accessioning.
How Home Collection Changes the Front End of the Lifecycle
The front end of the lifecycle looks different from an in-lab draw:
- A phlebotomist dispatch system schedules a technician to a patient’s home or a satellite collection point.
- Pickup windows have to account for travel time.
- Transport conditions, particularly temperature control for samples that degrade outside a narrow range, become a variable that simply doesn’t exist when collection happens inside the lab building.
The Added Traceability Burden of Decentralized Collection
That logistics layer adds a traceability burden that in-lab collection doesn’t carry. A dispatched phlebotomist, a transport courier, and the receiving lab all become links in the chain of custody before the sample ever gets accessioned. Each of those links needs the same scan-based tracking discipline described in Stage 2, applied earlier and across a wider physical distance.
Why Home-Collected Samples Still Need Standard Accessioning
Home collection changes how a sample begins its journey. However, specimen data must be tracked throughout its lifecycle, just as an on-site-collected specimen. Hence, accession is never an option. Labs building out a home collection program can find operational details on dispatching and tracking in CrelioHealth’s home sample collection guide.
Stage 7: Sample Archiving & Retention
After resulting, a sample is either disposed of or archived for a regulation-defined retention period, depending on the sample type and the test performed.
Why Labs Archive Samples After Resulting
Archiving exists for reasons beyond simple record-keeping. A stored specimen supports repeat testing when a result is questioned, gives a lab something to produce during an audit, satisfies legal hold requirements in the event of litigation, and, in some cases, becomes a resource for research use with appropriate consent.
Typical Retention Periods by Sample Type
Retention periods vary meaningfully by sample, test type, and by jurisdiction, so labs should treat CLIA and CAP guidance as the authoritative source rather than relying on a single universal number. The ranges below reflect commonly cited benchmarks from those frameworks.
| Sample / record type | Typical retention range | Governing reference |
|---|---|---|
| Test requisitions and authorizations | 2 years | CLIA Minimum |
| General test reports and results | 2 years (often longer by state law) | CLIA Minimum |
| Surgical pathology reports | 10 years | CAP checklist guidance |
| Histology slides | 10 years | CAP checklist guidance |
| Cytology slides | 5 years | CAP checklist guidance |
| Paraffin tissue blocks | 2 years minimum, longer in practice | CAP checklist guidance |
| Blood Bank/Immunohaematology specimens | 7 days post-transfusion | CLIA / AABB standards |
How LIMS Tracking Extends Into Long-Term Storage
Barcode and LIMS tracking doesn’t stop once a sample moves into storage. The same accession number and scan history that follows a specimen through testing extend into long-term storage, recording exactly which freezer, shelf, or archive location holds it and logging every retrieval event. That continuity is what lets a lab pull a two-year-old paraffin block for repeat testing without a manual search through paper logs.
Biorepository-scale storage, where labs manage tissue or specimen banks at volumes well beyond routine retention, is a distinct topic with its own operational and regulatory considerations and merits separate treatment. For standard sample archiving practices, CrelioHealth’s archiving guide covers the operational details.
Why Does Lab Sample Lifecycle Management Matter for Compliance and Lab Efficiency?
End-to-end visibility across all seven stages is what CLIA and CAP auditors check for during an inspection, and it’s also what determines whether a lab hits its turnaround-time targets.
Treat the seven stages as a single accountability chain rather than seven isolated tasks handled by seven separate teams. A gap at any one stage, whether it’s a missing barcode scan during tracking, a manual re-entry caused by poor LIS integration, or an archived record that doesn’t match the actual storage location, creates citation risk during an audit. Inspectors don’t evaluate stages in isolation. They trace a sample’s full path and expect the record to hold together at every handoff.
The business case runs parallel to the compliance case. Labs with strong sample lifecycle management see fewer lost or mislabeled samples, since tracking gaps get caught before they compound into a recollection. TAT improves because clean data at accessioning and segregation means less manual correction downstream at testing. And staff confidence rises because technologists spend less time chasing down where a sample went and more time on work that requires their expertise.
Lab sample management, in other words, isn’t just a back-office administrative function. It is the operational backbone that compliance and efficiency both depend on, which is exactly why labs treat gaps in it as urgent rather than cosmetic.
Frequently Asked Questions
What is the sample life cycle in LIMS?
The sample life cycle in LIMS is the tracked sequence a specimen moves through inside the system, from the moment it’s accessioned with a unique identifier to its final result and archived or disposed status. LIMS records every stage transition against that identifier, giving the lab a single, auditable record for each specimen.
What are the 7 stages of sample lifecycle management?
The seven stages are Collection & Accessioning, Tracking & Chain of Custody, Specimen Preparation & Segregation, LIS Integration, Specimen Processing & Testing, Home & Decentralized Collection, and Archiving & Retention.
What is sample accessioning?
Sample accessioning is the process of logging a specimen into the lab’s system and assigning it a unique accession number that ties every later action on that sample back to a single patient and order. CrelioHealth’s full guide on sample accessioning covers the process and common failure points in depth.
How long should lab samples be archived?
Retention periods vary by sample and test type and by jurisdiction, so there is no single universal number. CLIA and CAP guidance sets minimums that range from two years for general test records to ten years for surgical pathology reports and histology slides, and labs should confirm exact requirements against current CLIA and CAP checklists.
What is the chain of custody for a lab sample?
Chain of custody is the documented, unbroken record of who handled a sample, when, and what happened to it at each step from collection through final disposition. Barcode scans at every handoff are what make that record auditable. CrelioHealth’s chain-of-custody guide for regulated labs breaks down what inspectors check for.
Conclusion
Seven stages, one connected system. That’s the core idea worth carrying out of this guide: a lab’s sample lifecycle isn’t seven separate problems to solve independently; it’s a single chain where a gap anywhere weakens the whole thing. Lifecycle visibility is what turns compliance and efficiency from competing priorities into the same outcome, since the same tracking discipline that keeps an auditor satisfied is what keeps TAT on target and samples out of the lost-and-found pile.
If your lab is still mapping where its own gaps sit, start with whichever stage causes the most recurring pain, whether that’s accessioning errors, chain-of-custody documentation, LIS integration delays, or archiving logistics, and explore the dedicated guide for that stage linked above. For a broader look at how CrelioHealth’s LIMS supports sample tracking across all seven stages, that’s a natural next stop as well.
